NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
Details
- Buyer
- NHS England
- Supplier(s)
- Abbvie Ltd, Gilead Sciences Ltd, 280 High Holborn
- Value
- £160,000,000
- Duration
- 2 years
- Topic
- Pharmaceutical products
- Published
- 26 February 2026
- Source
- uk:find_a_tender
Tender description
Project title: NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives commencing 1st April 2026 Offer reference number: CM/TNS/25/5737 Period of framework: 1 April 2026 to 31 March 2028 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. ## Contract award Title: NHS England procurement for the supply of pangenotypic Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
Timeline
- Completed: Award date25 February 2026
- Completed: Award published26 February 2026Current notice
- Next: Contract expiry date31 March 2028in 2 years
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Every tender is advertised on Atamis, the NHS's single eCommercial system, and larger contracts appear on Find a Tender. Much of this procurement flows through framework agreements and the Crown Commercial Service. Clinical services are commissioned directly or through the Provider Selection Regime. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
UK health spending has nearly quadrupled to £241.8bn in 2024/25, £20bn up on the year before. £140.6bn of that went to procurement, the biggest sector of UK public spending and the fastest-growing.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
14 similar open tenders
See more open tenders related to NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives.
- Open tender
Generic Drugs - Injections/Infusions
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
Related topics
Topics related to NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives, ranked by notice volume.
- 44,616£7.6tn
Related buyers
Buyers similar to NHS England.
- 509£245.0m
- 431£15.3bn
- 427£117.3m
- 381£641.6m
- 321£18.9bn
- 298£3.1bn
- 297£1.7bn
- 269£1.2bn
- 153£987.8m
- 147£115.2m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
